What this site is, and what it is not.

What this site is

CJC-1295 Doctor is an independent editorial site that summarizes the published research literature on CJC-1295. The pages here are written as a reading list — a way to locate the small set of peer-reviewed papers, regulatory documents, and registered clinical trials that anchor the compound's evidence base, and to summarize what each of those sources actually says.

The target reader is a physician, a research scientist, a science journalist, or a careful lay reader who wants the underlying citations and not the marketing layer that surrounds most peptide content online. The site is single-author in voice but compiled from peer-reviewed primary sources; every quantitative claim is anchored to a citation.

What this site is not

This site is not a clinic, a pharmacy, a compounding service, a research-chemical vendor, or a treatment provider. It does not sell any product. It is not affiliated with ConjuChem (the original sponsor of CJC-1295's clinical development), with any compounding pharmacy, with any 'wellness clinic' that offers GHRH analog protocols, or with any peptide retailer.

It does not provide medical advice. The dosage page describes doses that appear in the published research; it does not recommend doses for any human research subject, patient, or athlete. CJC-1295 is not approved by the FDA or any other major regulator for any human indication, and it is prohibited at all times by the World Anti-Doping Agency for tested athletes.

Editorial standards

Every quantitative claim on this site cites a real, peer-reviewed primary source, a registered clinical trial, or a regulatory document with a DOI or permanent URL. Inline citations are numbered [N] and resolve to entries on the references page.

When a claim cannot be sourced to a peer-reviewed paper, it is either omitted or explicitly marked as deriving from a regulatory document or registry record. Where the literature is silent — for example, on long-term human safety beyond a few weeks — the silence is acknowledged rather than papered over with secondary-source assertions.

This site does not mention brand names of FDA-approved comparators, peptide vendor names, or compounding-pharmacy names. Where a comparator compound is discussed (sermorelin, tesamorelin, ipamorelin) it is named by its generic INN only.

Disclaimer

Nothing on this site constitutes medical advice. Nothing here is an endorsement of CJC-1295 for any human use. This site is an independent editorial digest of the published CJC-1295 research record — not a clinic, not a pharmacy, not a vendor, not a treatment provider. Readers seeking medical guidance should consult a licensed clinician. Readers subject to WADA testing should treat CJC-1295 as a prohibited substance at all times.